Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Other Non-Current Assets (2016 - 2025)

Marimed has reported Other Non-Current Assets over the past 13 years, most recently at $1.5 million for Q4 2025.

  • Quarterly Other Non-Current Assets changed 0.0% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $1.5 million for FY2025, 0.0% changed from the prior year.
  • Other Non-Current Assets was $1.5 million for Q4 2025 at Marimed, up from $1.1 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $13.0 million in Q1 2024 and troughed at $97950.0 in Q2 2021.
  • The 5-year median for Other Non-Current Assets is $1.1 million (2025), against an average of $3.6 million.
  • Year-over-year, Other Non-Current Assets surged 1229.59% in 2023 and then crashed 91.39% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $98000.0 in 2021, then surged by 944.9% to $1.0 million in 2022, then soared by 1124.32% to $12.5 million in 2023, then crashed by 88.04% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Other Non-Current Assets are $1.5 million (Q4 2025), $1.1 million (Q3 2025), and $1.1 million (Q2 2025).